Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients

  • Read more about Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

  • Read more about Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

Assiut University Registry for ACS Patients During COVID-19 Pandemic

  • Read more about Assiut University Registry for ACS Patients During COVID-19 Pandemic

Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases

  • Read more about Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases

A Study of Risk Factors for the COVID-19 Virus Infection

  • Read more about A Study of Risk Factors for the COVID-19 Virus Infection

Cardiovascular Manifestations of COVID-19

  • Read more about Cardiovascular Manifestations of COVID-19

The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients

  • Read more about The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

  • Read more about Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

  • Read more about Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

Canadian COVID-19 Emergency Department Registry

  • Read more about Canadian COVID-19 Emergency Department Registry

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 184
  • Page 185
  • Page 186
  • Page 187
  • Current page 188
  • Page 189
  • Page 190
  • Page 191
  • Page 192
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA